Inizio Evoke

Inizio Evoke company information, Employees & Contact Information

Explore related pages

Related company profiles:

Inizio Evoke is a global health marketing, communications, and transformation platform unlocking growth through data-driven insights and human centricity. We are purpose-built to make health more human™. With core expertise and specialty brands in Marketing, Comms, Transformation, Access, and Media, we serve as a premier partner for the world's most ambitious healthcare organizations. Proudly part of Inizio – the market-leading commercialization partner for health and life sciences. From early-stage development to loss of exclusivity, we simplify complexity, unlock value, and make collaboration seamless at every pivotal moment – unlocking growth through human insight and transformative creativity.
Looking for a particular Inizio Evoke employee's phone or email?

Inizio Evoke Questions

News

Taysha Gene Therapies to Release Third Quarter 2025 Financial Results and Host Conference Call and Webcast on November 4 - The Manila Times

Taysha Gene Therapies to Release Third Quarter 2025 Financial Results and Host Conference Call and Webcast on November 4 The Manila Times

MBX Biosciences to Participate in November Investor Conferences - Sahm

MBX Biosciences to Participate in November Investor Conferences Sahm

Inizio Evoke: 2025 - PharmaLive

Inizio Evoke: 2025 PharmaLive

BBOT Announces Poster Presentations at the 2025 - GlobeNewswire

BBOT Announces Poster Presentations at the 2025 GlobeNewswire

Spruce Biosciences Resumes Trading on the Nasdaq Capital Market - Business Wire

Spruce Biosciences Resumes Trading on the Nasdaq Capital Market Business Wire

Spruce Biosciences Resumes Trading on the Nasdaq Capital Market - FinancialContent

Spruce Biosciences Resumes Trading on the Nasdaq Capital Market FinancialContent

BBOT to Participate in Upcoming September Investor Healthcare Conferences - GlobeNewswire

BBOT to Participate in Upcoming September Investor Healthcare Conferences GlobeNewswire

MindImmune Awarded Grant to Accelerate IND-Enabling Studies through Rhode Island Life Science Hub - Business Wire

MindImmune Awarded Grant to Accelerate IND-Enabling Studies through Rhode Island Life Science Hub Business Wire

Evoke unveils simplified brand and structure: Inizio Evoke - PR Newswire

Evoke unveils simplified brand and structure: Inizio Evoke PR Newswire

Spruce Biosciences Resumes Trading on the Nasdaq Capital Market - Investing News Network

Spruce Biosciences Resumes Trading on the Nasdaq Capital Market Investing News Network

Biocom California Opposes Most Favored Nation Price Setting Policy - Business Wire

Biocom California Opposes Most Favored Nation Price Setting Policy Business Wire

Kelonia Therapeutics to Present iGPS® Preclinical Data at the American Society of Gene & Cell Therapy (ASGCT) 2025 Annual Meeting - Business Wire

Kelonia Therapeutics to Present iGPS® Preclinical Data at the American Society of Gene & Cell Therapy (ASGCT) 2025 Annual Meeting Business Wire

Blue Lake Biotechnology to Present Safety and Immunogenicity Data for its RSV Intranasal Vaccine Candidate at the 13 - Business Wire

Blue Lake Biotechnology to Present Safety and Immunogenicity Data for its RSV Intranasal Vaccine Candidate at the 13 Business Wire

Affini-T Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire

Affini-T Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference Business Wire

BlossomHill Therapeutics Doses Patients in the First Cohort of the Phase 1/2 SOLARA Clinical Trial of BH-30643 for EGFR- and HER2-Mutated Non-Small Cell Lung Cancer - Business Wire

BlossomHill Therapeutics Doses Patients in the First Cohort of the Phase 1/2 SOLARA Clinical Trial of BH-30643 for EGFR- and HER2-Mutated Non-Small Cell Lung Cancer Business Wire

Blue Lake and CyanVac Report Positive Phase 2a Data for Intranasal COVID-19 Vaccine Candidate - Business Wire

Blue Lake and CyanVac Report Positive Phase 2a Data for Intranasal COVID-19 Vaccine Candidate Business Wire

Xencor Appoints Raymond Deshaies, Ph.D., to Board of Directors - Business Wire

Xencor Appoints Raymond Deshaies, Ph.D., to Board of Directors Business Wire

Biocom California and Los Angeles County Economic Development Corporation Renew Memorandum of Understanding to Advance the Greater Los Angeles Life Science Ecosystem - Business Wire

Biocom California and Los Angeles County Economic Development Corporation Renew Memorandum of Understanding to Advance the Greater Los Angeles Life Science Ecosystem Business Wire

Blue Lake and CyanVac Publish Full Data from Open Label Phase 1 Clinical Study of COVID-19 Vaccine Candidate - Business Wire

Blue Lake and CyanVac Publish Full Data from Open Label Phase 1 Clinical Study of COVID-19 Vaccine Candidate Business Wire

Spruce Biosciences Announces $50.0 Million Private Placement Financing - Business Wire

Spruce Biosciences Announces $50.0 Million Private Placement Financing Business Wire

Spruce Biosciences Announces Conditional Nasdaq Approval to Resume Trading on the Nasdaq Capital Market - Business Wire

Spruce Biosciences Announces Conditional Nasdaq Approval to Resume Trading on the Nasdaq Capital Market Business Wire

Spruce Biosciences Receives U.S. FDA Breakthrough Therapy Designation for Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) in Sanfilippo Syndrome Type B (MPS IIIB) - Business Wire

Spruce Biosciences Receives U.S. FDA Breakthrough Therapy Designation for Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) in Sanfilippo Syndrome Type B (MPS IIIB) Business Wire

Spruce Biosciences Announces Reverse Stock Split - Business Wire

Spruce Biosciences Announces Reverse Stock Split Business Wire

Biocom California Establishes International Collaboration with BPI to Bolster Cooperation Between Both Organizations - Business Wire

Biocom California Establishes International Collaboration with BPI to Bolster Cooperation Between Both Organizations Business Wire

Aardvark Therapeutics Appoints Renowned Biopharma Leaders Roy D. Baynes and Susan E. Graf to its Board of Directors - Business Wire

Aardvark Therapeutics Appoints Renowned Biopharma Leaders Roy D. Baynes and Susan E. Graf to its Board of Directors Business Wire

Xencor Presents Initial Data for XmAb819, a First-in-class ENPP3 x CD3 Bispecific T-Cell Engager, in Development for Clear Cell Renal Cell Carcinoma - FinancialContent

Xencor Presents Initial Data for XmAb819, a First-in-class ENPP3 x CD3 Bispecific T-Cell Engager, in Development for Clear Cell Renal Cell Carcinoma FinancialContent

Terremoto Biosciences Appoints Charles Baum, M.D., Ph.D., as Chief Executive Officer - Business Wire

Terremoto Biosciences Appoints Charles Baum, M.D., Ph.D., as Chief Executive Officer Business Wire

Terremoto Biosciences Appoints James Christensen, Ph.D., as President and Head of Research & Development - Business Wire

Terremoto Biosciences Appoints James Christensen, Ph.D., as President and Head of Research & Development Business Wire

Nucleix to Present Data Showcasing Performance and Clinical Utility of Bladder EpiCheck® Monitoring in Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence at AUA 2025 - The AI Journal

Nucleix to Present Data Showcasing Performance and Clinical Utility of Bladder EpiCheck® Monitoring in Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence at AUA 2025 The AI Journal

BBOT Announces First Patient Dosed with BBO-11818, a PanKRAS Dual Inhibitor in the Phase 1 KONQUER-101 Trial for Advanced Solid Tumors - Business Wire

BBOT Announces First Patient Dosed with BBO-11818, a PanKRAS Dual Inhibitor in the Phase 1 KONQUER-101 Trial for Advanced Solid Tumors Business Wire

Statement from Biocom California and MassBio on America’s Biotechnology Leadership and National Security - Business Wire

Statement from Biocom California and MassBio on America’s Biotechnology Leadership and National Security Business Wire

io9 Announces Publication in the Journal of Clinical Oncology Demonstrating Efficacy of OncoGaze™, its Next-Generation AI Platform Poised to Eliminate Delays and Inequities in Correct First-Line Precision Treatment Selection for Cancer Patients - Business Wire

io9 Announces Publication in the Journal of Clinical Oncology Demonstrating Efficacy of OncoGaze™, its Next-Generation AI Platform Poised to Eliminate Delays and Inequities in Correct First-Line Precision Treatment Selection for Cancer Patients Business Wire

venBio Raises $528 Million Venture Capital Fund Focused on Life Science Companies - Business Wire

venBio Raises $528 Million Venture Capital Fund Focused on Life Science Companies Business Wire

Kelonia Therapeutics to Present Preclinical Data Highlighting Therapeutic Potential of in vivo CAR-T Cell Therapy in Multiple Myeloma - Business Wire

Kelonia Therapeutics to Present Preclinical Data Highlighting Therapeutic Potential of in vivo CAR-T Cell Therapy in Multiple Myeloma Business Wire

California’s Life Science Industry Generates $414.2 Billion Annually - Business Wire

California’s Life Science Industry Generates $414.2 Billion Annually Business Wire

Kelonia Therapeutics to Participate in Upcoming Scientific Conferences - Business Wire

Kelonia Therapeutics to Participate in Upcoming Scientific Conferences Business Wire

Synthekine Granted U.S. FDA Fast Track Designation for CD19 CAR-T and Orthogonal IL-2 Investigational Therapy, SYNCAR-001 + STK-009, for the Treatment of Lupus Without Lymphodepletion - Business Wire

Synthekine Granted U.S. FDA Fast Track Designation for CD19 CAR-T and Orthogonal IL-2 Investigational Therapy, SYNCAR-001 + STK-009, for the Treatment of Lupus Without Lymphodepletion Business Wire

CyanVac Receives BARDA-Funded Project NextGen Award to Evaluate its Intranasal COVID-19 Vaccine Candidate in a Phase 2b Study - Business Wire

CyanVac Receives BARDA-Funded Project NextGen Award to Evaluate its Intranasal COVID-19 Vaccine Candidate in a Phase 2b Study Business Wire

Tim Scott to Succeed Joe Panetta as Biocom California President and CEO - Business Wire

Tim Scott to Succeed Joe Panetta as Biocom California President and CEO Business Wire

Inipharm to Present Pharmacokinetic Data From a Phase 1 Clinical Trial of INI-822, a Small Molecule Inhibitor of HSD17B13 - Business Wire

Inipharm to Present Pharmacokinetic Data From a Phase 1 Clinical Trial of INI-822, a Small Molecule Inhibitor of HSD17B13 Business Wire

BlossomHill Therapeutics Closes $100 Million Series B Financing - Business Wire

BlossomHill Therapeutics Closes $100 Million Series B Financing Business Wire

Spruce Biosciences Recognized as a Bay Area Best Place to Work - FinancialContent

Spruce Biosciences Recognized as a Bay Area Best Place to Work FinancialContent

Top Inizio Evoke Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant